Page last updated: 2024-08-05 13:10:23

triazolopyridazine

null

ChEBI ID: 48384

Members (6)

MemberDefinitionRole
3-[(4-fluorophenyl)methylthio]-6-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazine3-[(4-fluorophenyl)methylthio]-6-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazine
3-methyl-6-(1-pyrrolidinyl)-[1,2,4]triazolo[4,3-b]pyridazine3-methyl-6-(1-pyrrolidinyl)-[1,2,4]triazolo[4,3-b]pyridazine
3-methyl-6-prop-2-enoxy-[1,2,4]triazolo[4,3-b]pyridazine3-methyl-6-prop-2-enoxy-[1,2,4]triazolo[4,3-b]pyridazine
6-(2-furanyl)-3-(2-pyridinylmethylthio)-[1,2,4]triazolo[4,3-b]pyridazine6-(2-furanyl)-3-(2-pyridinylmethylthio)-[1,2,4]triazolo[4,3-b]pyridazine
AMG-208A member of the class of quinolines that is 7-methoxyquinoline substituted at position 4 by a (6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy group. AMG exhibits antitumour activity, particularly in prostate cancer.AMG-208
sgx 523A member of the class of triazolopyridazines that is 6-(1-methylpyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazine-3-thiol in which the thiol hydrogen is replaced by a quinolin-6-yl group.SGX-523

Research

Studies (33)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (12.12)29.6817
2010's21 (63.64)24.3611
2020's8 (24.24)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials1 (1.67%)5.53%
Reviews2 (3.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other57 (95.00%)84.16%